6-dodecyl-2-methoxy-1,4-benzoquinone has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, Z; Huang, R; Huang, T; Jiang, L; Li, J; Lu, S; Phama, HTT; Wei, J; Wei, X; Xie, Q; Xu, X; Ye, F; Zhang, H | 1 |
1 other study(ies) available for 6-dodecyl-2-methoxy-1,4-benzoquinone and Alzheimer Disease
| Article | Year |
|---|---|
Protective effect of 2-dodecyl-6-methoxycyclohexa-2, 5-diene-1, 4-dione, isolated from Averrhoa carambola L., against Aβ1-42-induced apoptosis in SH-SY5Y cells by reversing Bcl-2/Bax ratio.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Apoptosis; Averrhoa; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Survival; Cyclohexenes; Drugs, Chinese Herbal; Humans; Membrane Potential, Mitochondrial; Peptide Fragments; Proto-Oncogene Proteins c-bcl-2 | 2021 |